136 related articles for article (PubMed ID: 12400766)
1. Serum levels of prophylactic cefazolin during cardiopulmonary bypass surgery.
Fellinger EK; Leavitt BJ; Hebert JC
Ann Thorac Surg; 2002 Oct; 74(4):1187-90. PubMed ID: 12400766
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic characteristics and microbiologic appropriateness of cefazolin for perioperative antibiotic prophylaxis in elective cardiac surgery.
Lanckohr C; Horn D; Voeller S; Hempel G; Fobker M; Welp H; Koeck R; Ellger B
J Thorac Cardiovasc Surg; 2016 Aug; 152(2):603-10. PubMed ID: 27209020
[TBL] [Abstract][Full Text] [Related]
3. Cefazolin concentrations in serum during cardiopulmonary bypass surgery.
Miglioli PA; Merlo F; Calabrò GB; Allerberger F; Fille M
Drugs Exp Clin Res; 2005; 31(1):29-33. PubMed ID: 15921027
[TBL] [Abstract][Full Text] [Related]
4. Population pharmacokinetics of cefazolin before, during and after cardiopulmonary bypass in adult patients undergoing cardiac surgery.
Asada M; Nagata M; Mizuno T; Uchida T; Takahashi H; Makita K; Arai H; Kijima S; Echizen H; Yasuhara M
Eur J Clin Pharmacol; 2021 May; 77(5):735-745. PubMed ID: 33211137
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of cefazolin antimicrobial prophylaxis during cardiac surgery with cardiopulmonary bypass.
Calic D; Ariano RE; Arora RC; Grocott HP; Lakowski TM; Lillico R; Zelenitsky SA
J Antimicrob Chemother; 2018 Mar; 73(3):768-771. PubMed ID: 29237016
[TBL] [Abstract][Full Text] [Related]
6. Impact of Intraoperative Continuous-Infusion Versus Intermittent Dosing of Cefazolin Therapy on the Incidence of Surgical Site Infections After Coronary Artery Bypass Grafting.
Shoulders BR; Crow JR; Davis SL; Whitman GJ; Gavin M; Lester L; Barodka V; Dzintars K
Pharmacotherapy; 2016 Feb; 36(2):166-73. PubMed ID: 26799442
[TBL] [Abstract][Full Text] [Related]
7. A pilot study to determine the feasibility of continuous cefazolin infusion.
Waltrip T; Lewis R; Young V; Farmer M; Clayton S; Myers S; Gray LA; Galandiuk S
Surg Infect (Larchmt); 2002; 3(1):5-9. PubMed ID: 12593694
[TBL] [Abstract][Full Text] [Related]
8. Population pharmacokinetics of cefazolin before, during and after cardiopulmonary bypass to optimize dosing regimens for children undergoing cardiac surgery.
De Cock PA; Mulla H; Desmet S; De Somer F; McWhinney BC; Ungerer JP; Moerman A; Commeyne S; Vande Walle J; Francois K; Van Hasselt JG; De Paepe P
J Antimicrob Chemother; 2017 Mar; 72(3):791-800. PubMed ID: 27999040
[TBL] [Abstract][Full Text] [Related]
9. Skeletal muscle and plasma concentrations of cefazolin during cardiac surgery in infants.
Himebauch AS; Nicolson SC; Sisko M; Moorthy G; Fuller S; Gaynor JW; Zuppa AF; Fox E; Kilbaugh TJ
J Thorac Cardiovasc Surg; 2014 Dec; 148(6):2634-41. PubMed ID: 25131168
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of cefazolin delivery via the cardiopulmonary bypass circuit priming solution in infants and children.
Cies JJ; Moore WS; Parker J; Stevens R; Al-Qaqaa Y; Enache A; Chopra A
J Antimicrob Chemother; 2019 May; 74(5):1342-1347. PubMed ID: 30689931
[TBL] [Abstract][Full Text] [Related]
11. Plasma cefazolin levels during cardiovascular surgery: effects of cardiopulmonary bypass and profound hypothermic circulatory arrest.
Caffarelli AD; Holden JP; Baron EJ; Lemmens HJ; D'Souza H; Yau V; Olcott C; Reitz BA; Miller DC; van der Starre PJ
J Thorac Cardiovasc Surg; 2006 Jun; 131(6):1338-43. PubMed ID: 16733167
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of Cefazolin and Vancomycin in Infants Undergoing Open-Heart Surgery With Cardiopulmonary Bypass.
Ingrande J; Gutierrez K; Lemmens HJ; Verma A; Nicolau DP; Sutherland CA; Ramamoorthy C
Anesth Analg; 2019 May; 128(5):935-943. PubMed ID: 30995208
[TBL] [Abstract][Full Text] [Related]
13. Plasma concentrations of cefazolin in pediatric patients undergoing cardiac surgery.
Lapmahapaisan S; Maisat W; Tantiwongkosri K; Jutasompakorn P; Sisan W
Ann Card Anaesth; 2021; 24(2):149-154. PubMed ID: 33884969
[TBL] [Abstract][Full Text] [Related]
14. Effects of cardiopulmonary bypass on the disposition of cefazolin in patients undergoing cardiothoracic surgery.
Asada M; Nagata M; Mizuno T; Uchida T; Kurashima N; Takahashi H; Makita K; Arai H; Echizen H; Yasuhara M
Pharmacol Res Perspect; 2018 Dec; 6(6):e00440. PubMed ID: 30410768
[TBL] [Abstract][Full Text] [Related]
15. Validation of a Dosing Strategy for Cefazolin for Surgery Requiring Cardiopulmonary Bypass.
Hollis AL; Heil EL; Nicolau DP; Odonkor P; Dowling TC; Thom KA
Surg Infect (Larchmt); 2015 Dec; 16(6):829-32. PubMed ID: 26291478
[TBL] [Abstract][Full Text] [Related]
16. Cefazolin and netilmicin serum levels during and after cardiac surgery with cardiopulmonary bypass.
Lehot JJ; Reverdy ME; Etienne J; Corot C; Nervi C; Sear J; Fleurette J; Estanove S
J Cardiothorac Anesth; 1990 Apr; 4(2):204-9. PubMed ID: 2131868
[TBL] [Abstract][Full Text] [Related]
17. Serum cefazolin levels during cardiopulmonary bypass.
Akl BF; Richardson G
Ann Thorac Surg; 1980 Feb; 29(2):109-12. PubMed ID: 7356361
[TBL] [Abstract][Full Text] [Related]
18. Optimal Cefazolin Prophylactic Dosing for Bariatric Surgery: No Need for Higher Doses or Intraoperative Redosing.
Chen X; Brathwaite CE; Barkan A; Hall K; Chu G; Cherasard P; Wang S; Nicolau DP; Islam S; Cunha BA
Obes Surg; 2017 Mar; 27(3):626-629. PubMed ID: 27520693
[TBL] [Abstract][Full Text] [Related]
19. Cefazolin and linezolid penetration into sternal cancellous bone during coronary artery bypass grafting.
Andreas M; Zeitlinger M; Wisser W; Jaeger W; Maier-Salamon A; Thalhammer F; Kocher A; Hiesmayr JM; Laufer G; Hutschala D
Eur J Cardiothorac Surg; 2015 Nov; 48(5):758-64. PubMed ID: 25527166
[TBL] [Abstract][Full Text] [Related]
20. Prophylactic Cefazolin Dosing in Women With Body Mass Index >35 kg·m-2 Undergoing Cesarean Delivery: A Pharmacokinetic Study of Plasma and Interstitial Fluid.
Eley VA; Christensen R; Ryan R; Jackson D; Parker SL; Smith M; van Zundert AA; Wallis SC; Lipman J; Roberts JA
Anesth Analg; 2020 Jul; 131(1):199-207. PubMed ID: 32250982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
